Clinical Study

In This Study, Doctors Want To Evaluate The Safety And Effectiveness Of An Investigational Drug In Patients With Attenuated Psychosis Syndrome.

Posted Date: Jan 28, 2020

  • Investigator: Caleb Adler
  • Specialties: Adolescent Psychiatry/Psychology, Psychiatry/Psychology
  • Type of Study: Drug

A phase II randomised, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of orally administered BI 409306 during a 52-week treatment period as an early intervention in patients with attenuated psychosis syndrome.


Age =16 And = 30 Years, Diagnostic Criteria For Attenuated Psychosis Syndrome


Psychotic, Young Adults, Adolescent

For More Information:

Raechel Cooley, B.A.

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.